UBS has upgraded IMCD to “neutral” due to its valuation reflecting earnings pressures. The specialty chemicals and food ingredients company has faced challenges in its earnings, prompting the upgrade. The decision by UBS comes as the company continues to navigate through the current market conditions.

Read more at Investing.com: UBS upgrades IMCD to “neutral” as valuation reflects earnings pressures